AMWL

American Well Corp
NYSEHEALTHCAREHEALTH INFORMATION SERVICES

Key Statistics

Market Cap
$185.30M
P/E Ratio
EPS
$-5.45
Beta
1.70
52W High
$13.45
52W Low
$3.71
50-Day MA
$9.37
200-Day MA
$6.25
Dividend Yield
Profit Margin
-37.00%
Forward P/E
PEG Ratio

About American Well Corp

American Well Corporation is a telehealth business enabling digital healthcare delivery. The company is headquartered in Boston, Massachusetts.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$237.38M
Gross Profit (TTM)$127.70M
EBITDA$-46.32M
Operating Margin-23.60%
Return on Equity-31.80%
Return on Assets-13.40%
Revenue/Share (TTM)$14.58
Book Value$13.65
Price-to-Book0.81
Price-to-Sales (TTM)0.78
EV/Revenue0.0395
EV/EBITDA-0.81
Quarterly Earnings Growth (YoY)0.00%
Quarterly Revenue Growth (YoY)-17.90%
Shares Outstanding$15.06M
Float$11.72M
% Insiders5.42%
% Institutions46.01%

Historical Volatility

HV 10-Day
118.23%
HV 20-Day
98.25%
HV 30-Day
86.00%
HV 60-Day
77.79%
HV Rank
94.4%

Volatility is currently expanding

Analyst Ratings

Consensus ($8.90 target)
1
Buy
6
Hold

Latest News

Amwell® to report second quarter 2026 operating results

BOSTON, July 24, 2026 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, will report second quarter 2026 operating results after stock market trading hours on Tuesday, August 4. Following the distribution of the earnings release via wire services, the Amwell management team will host a live conference call and webcast at 5 p.m.

GlobeNewsWire7/24/2026Neutral
American Well (AMWL) Moves 9.4% Higher: Will This Strength Last?

American Well (AMWL) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Zacks Investment Research6/29/2026Positive
Nature Human Behaviour study finds SilverCloud® by Amwell® reduced prevalence of mental disorders over two years at scale

BOSTON, May 18, 2026 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, today highlighted results from an independently led, National Institute of Mental Health-funded randomized trial published in Nature Human Behaviour examining SilverCloud® by Amwell ® , the company's digital behavioral health solution.

GlobeNewsWire5/18/2026Neutral
Amwell® to Participate in Upcoming Investor Conference

BOSTON, May 11, 2026 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, today announced that Mark Hirschhorn, CFO and COO, will participate in the 21st Annual Needham Technology, Media & Consumer Conference, taking place virtually on May 14, including a presentation at 2:15 p.m. ET. An audio webcast of the fireside chat will be available at investors.amwell.com.

GlobeNewsWire5/11/2026Neutral

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on AMWL and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More HEALTHCARE Stocks

Data last updated: 7/29/2026